Rajiv Patni, M.D. has been appointed chief development officer at Ocera Therapeutics, Inc., effective September 2, 2014. Dr. Patni previously served as senior vice president for Actelion U.S. He also served as vice president at Roche and held leadership positions at Novartis and Pfizer.   “I am delighted to have Rajiv join our management team and expect that he will make significant contributions to the development of OCR-002,” said Linda Grais, M.D., chief executive officer of Ocera...